Form 4: Director Nancy Cocozza Receives Privia Health Equity Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Director Nancy Cocozza was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Summary

  • Director Nancy Cocozza acquired 8,463 restricted stock units (RSUs) on May 20, 2026.
  • The grant was issued under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan.
  • Following this transaction, the director's total beneficial ownership of common stock increased to 42,814 shares.
  • The RSUs are scheduled to vest on the earlier of the day before the 2027 annual meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of immediate market impact.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • None identified.

Risks

  • Standard market risks associated with equity ownership and potential volatility in the healthcare services sector.

Future Outlook

The RSUs are expected to vest by May 20, 2027, or upon the 2027 annual meeting of stockholders, whichever occurs first.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the healthcare technology and services industry to ensure board alignment with company performance.

Comparison to Industry Standards

  • The use of restricted stock units for director compensation is consistent with standard practices for mid-cap healthcare companies.
  • The vesting schedule aligns with typical one-year cliff vesting cycles observed in public company board compensation packages.

Stakeholder Impact

  • Shareholders: Increased alignment between director incentives and company performance.

Next Steps

  • Vesting of the 8,463 restricted stock units by May 2027.

Key Dates

DateDescription
05/20/2026Date of the restricted stock unit grant transaction.
05/22/2026Date the Form 4 was filed with the SEC.

Keywords

Privia Health, PRVA, Form 4, Insider Trading, Equity Compensation, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.